Literature DB >> 19672564

[Infections with respiratory syncytial virus. Underestimated risk during anaesthesia in infants].

J Wörner1, M Jöhr, T M Berger, P Christen.   

Abstract

Infections with respiratory syncytial virus (RSV) are responsible for a large proportion of seasonal winter airway diseases. After an infection with RSV no persistent immunity remains. Adults show no or only a few symptoms similar to the common cold. However, in preterm and newborn children RSV infections lead to severe and even life-threatening bronchiolitis. These children require supplementary oxygen and often need respiratory support. The infection with RSV considerably enhances the risk of anaesthesia-related complications in infants. So far this problem has rarely been mentioned in the literature. We report on an infant with a RSV infection who was ventilation-dependent for 9 days after anaesthesia for a minor intervention.

Entities:  

Mesh:

Year:  2009        PMID: 19672564     DOI: 10.1007/s00101-009-1598-9

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  5 in total

Review 1.  Anesthesia for the child with an upper respiratory tract infection: still a dilemma?

Authors:  Alan R Tait; Shobha Malviya
Journal:  Anesth Analg       Date:  2005-01       Impact factor: 5.108

2.  Clinical impact of preoperative respiratory syncytial virus testing.

Authors:  R C Manworren; C Conner; M Myers; K McCarthy
Journal:  AORN J       Date:  1999-05       Impact factor: 0.676

3.  Incidence of and risk factors for airway complications following endotracheal intubation for bronchiolitis.

Authors:  Jeffrey Jorgensen; Julie L Wei; Kevin J Sykes; Stephen A Klem; Robert A Weatherly; Daniel E Bruegger; Adriane D Latz; Pamela J Nicklaus
Journal:  Otolaryngol Head Neck Surg       Date:  2007-09       Impact factor: 3.497

4.  The causal direction in the association between respiratory syncytial virus hospitalization and asthma.

Authors:  Lone Graff Stensballe; Jacob Brunbjerg Simonsen; Simon Francis Thomsen; Anne-Marie Hellesøe Larsen; Susan Hovmand Lysdal; Peter Aaby; Kirsten Ohm Kyvik; Axel Skytthe; Vibeke Backer; Hans Bisgaard
Journal:  J Allergy Clin Immunol       Date:  2009-01       Impact factor: 10.793

5.  Pre-existing disease is associated with a significantly higher risk of death in severe respiratory syncytial virus infection.

Authors:  K Thorburn
Journal:  Arch Dis Child       Date:  2008-07-24       Impact factor: 3.791

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.